. 2020 Apr 7;19(9):1059–1065. doi: 10.1080/15384101.2020.1747776
© 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Figure 3.
miR-33a is the direct target of lncRNA MCF2L-AS1.